Publications by authors named "Anna Mann"

Claim this Profile
C
Corrigendum to "Ambiguous animals, ambivalent carers and arbitrary care collectives: Re-theorizing resistance to social robots in healthcare" [Soc. Sci. Med. Volume 365, January 2025, 117587].
Tanja Ahlin, Anna Mann

Soc Sci Med· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Ambiguous animals, ambivalent carers and arbitrary care collectives: Re-theorizing resistance to social robots in healthcare.
Tanja Ahlin, Anna Mann

Soc Sci Med· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Canadian guidance for diagnosis and management of acute hepatic porphyrias.
Juan Francisco Idiaquez, Aditi Khandelwal, Bassam A Nassar, Andrea J Thoni, Anna Mann

Clin Biochem· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
'
'To improve quality of life': Diverging enactments of a value in nephrology clinical practices.
Anna Mann

Health (London)· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Generation of nanobodies from transgenic 'LamaMice' lacking an endogenous immunoglobulin repertoire.
Thomas Eden, Alessa Z Schaffrath, Janusz Wesolowski, Tobias Stähler, Natalie Tode, Anna M Mann

Nat Commun· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and management of protoporphyria-related liver dysfunction in erythropoietic protoporphyria and x-linked protoporphyria: A patient-friendly summary of the 2023 evidence-based consensus guidelines.
Anna K Mann, Liz Allan, Kristen P Wheeden, Amy K Dickey, Cynthia Levy

Clin Liver Dis (Hoboken)· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Administration of an AAV vector coding for a P2X7-blocking nanobody-based biologic ameliorates colitis in mice.
Catalina Abad, Mélanie Demeules, Charlotte Guillou, Henri Gondé, Rachid Zoubairi, Anna Marei Mann

J Nanobiotechnology· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of nanobody-based biologics targeting purinergic checkpoints in tumor models .
Mélanie Demeules, Allan Scarpitta, Romain Hardet, Henri Gondé, Catalina Abad, Anna Marei Mann

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting multiple myeloma with nanobody-based heavy chain antibodies, bispecific killer cell engagers, chimeric antigen receptors, and nanobody-displaying AAV vectors.
Julia Hambach, Anna Marei Mann, Peter Bannas, Friedrich Koch-Nolte

Front Immunol· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Enhanced Transduction of P2X7-Expressing Cells with Recombinant rAAV Vectors.
Anna Marei Mann, Waldemar Schäfer, Sahil Adriouch, Kathleen Börner, Dirk Grimm

Methods Mol Biol· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The voices of family caregivers of seniors with chronic conditions: a window into their experience using a qualitative design.
Suzette Brémault-Phillips, Jasneet Parmar, Melissa Johnson, Arlene Huhn, Anna Mann

Springerplus· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis